(Q33362177)

26 July 2017

title

Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study (English)

1 reference

26 July 2017

1 reference

Sebastian Schneeweiss

series ordinal

2

object named as

Sebastian Schneeweiss

1 reference

26 July 2017

4

Jeffrey N Katz

1 reference

26 July 2017

7

Jerry Avorn

1 reference

26 July 2017

8

Daniel H Solomon

1 reference

26 July 2017

5

Michael E Weinblatt

1 reference

26 July 2017

Gladys Ting

1

1 reference

26 July 2017

Richard Scranton

series ordinal

3

1 reference

26 July 2017

Melissa Young

series ordinal

6

1 reference

26 July 2017

publication date

21 August 2008

1 reference

Arthritis Research and Therapy

26 July 2017

published in

1 reference

26 July 2017

volume

10

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

R95

1 reference

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575609

The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575609

Performance of a rheumatoid arthritis records-based index of severity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575609

Development and assessment of indicators of rheumatoid arthritis severity: results of a Delphi panel

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575609

Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575609

Predictors of infection in rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575609

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575609

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575609

Controlling for confounding by indication for treatment. Are administrative data equivalent to clinical data?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575609

Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575609

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575609

Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575609

Death rates and causes of death in patients with rheumatoid arthritis: a population-based study

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575609

Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575609

The ICD-9-based illness severity score: a new model that outperforms both DRG and APR-DRG as predictors of survival and resource utilization.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575609

Neurological complications of infliximab

31 October 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/18717997

12 December 2020

Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/18717997

12 December 2020

Incidence of Cancer Among Patients With Rheumatoid Arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18717997

12 December 2020

Confounding by indication

1 reference

https://pubmed.ncbi.nlm.nih.gov/18717997

12 December 2020

Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18717997

12 December 2020

Identifiers

DOI

10.1186/AR2482

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference